Premium
P1‐160: Cerebral glucose metabolism in a 5XFAD butyrylcholinesterase‐knockout mouse model of Alzheimer's disease
Author(s) -
DeBay Drew R.,
Macdonald Ian R.,
Reid Andrew G.,
Cash Meghan,
Mawko George,
Burrell Steve,
Martin Earl,
Bowen Chris V.,
Darvesh Sultan
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.359
Subject(s) - butyrylcholinesterase , cholinergic , medicine , endocrinology , alzheimer's disease , pittsburgh compound b , pathology , amyloid (mycology) , dementia , neuroscience , acetylcholinesterase , disease , psychology , chemistry , aché , biochemistry , enzyme
A. Claudio Cuello, Pedro Rosa-Neto, McGill University Centre for Studies in Aging, Verdun, QC, Canada; Translational Imaging Laboratory, Verdun, QC, Canada; Federal University of Rio Grande dos Sul, Porto Alegre, Brazil; McGill Centre for Studies in Aging, Verdun, QC, Canada; McGill Centre for Studies in Aging, Montreal, QC, Canada; McGill University, Montreal, QC, Canada; McConnell Brain Imaging Centre, Montr eal, QC, Canada; McGill University, Montr eal, QC, Canada; Universit e de Montr eal, Montr eal, QC, Canada; Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD Centre), Douglas Mental Health Institute, Montreal, QC, Canada; Douglas Hospital Research Centre, Montreal, QC, Canada; Translational Imaging Laboratory, Montreal, QC, Canada. Contact e-mail: peter.ms.kang@gmail. com